Personalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Deverra Therapeuticsdeverratx.com |
Deverra Therapeutics is a clinical-stage biotechnology company developing allogeneic, off-the-shelf cellular immunotherapies from | Seattle, Washington | 1-10 | — |
Mesoblastmesoblast.com  JH DJMS |
Mesoblast is a biotechnology company developing and commercializing allogeneic cellular medicines — off-the-shelf mesenchymal line | Melbourne, VIC | 51-200 | — |
Gamida Cellgamida-cell.com |
Gamida Cell is a cell therapy company that develops allogeneic cell therapy products using its proprietary nicotinamide (NAM) tech | Boston, Massachusetts | 51-200 | — |
AlloVirallovir.com BH  DSFV |
AlloVir (formerly ViraCyte) is a biotechnology company developing allogeneic, multi-virus specific T cell therapies that restore n | Waltham, Massachusetts | 11-50 | — |
Cord Biacord-bia.com |
— | — | — | |
Cord Bloodcord-blood.com |
— | — | — | |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Crispertherapeuticscrispertherapeutics.com |
— | — | — | |
Orgenesisorgenesis.com  DSSNAB |
Orgenesis is a global biotechnology company founded in 2012 that builds the POCare Platform — a network of partnerships with acade | Germantown, Maryland | 11-50 | — |
CatalYmcatalym.com SRSC  SR |
CatalYm is a biotechnology company developing visugromab, an antibody that neutralizes GDF-15 to reverse immune resistance mechani | Martinsried, Bayern | 51-200 | — |
| Run live for more | ||||
Deverra Therapeutics is a clinical-stage biotechnology company developing allogeneic, off-the-shelf cellular immunotherapies from donor umbilical cord blood cells for cancer and infectious disease treatment, with three programs including Dilanubicel in a global phase 2 randomized controlled trial.
Companies like Deverra Therapeutics include Mesoblast, Gamida Cell, AlloVir, Cord Bia, Cord Blood. See the full list of 24 competitors and alternatives above.
Deverra Therapeutics has approximately 1-10 employees and is in the Biotechnology industry.
Deverra Therapeutics is headquartered in Seattle, Washington.
Deverra Therapeutics operates in the Biotechnology industry.
Key decision-makers and buying contacts at Deverra Therapeutics are listed above, including leaders across executive, finance, sales and operations.